Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer

International Urology and Nephrology

Volumn 31, Issue 1, 1999, Pages 95-99

  Elgun S ^a   Keskinege A ^a   Yilmaz, E ^a   Baltaci, S ^a   Beduk Y ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ARGINASE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; SPECTROPHOTOMETRY;

ACID PHOSPHATASE; AGED; ARGINASE; ENZYME TESTS; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES;

EID: 0033028706     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007132109061     Document Type: Article

References (15)

1. Pretlow II, T. G., Harris, B. E., Bradley, E. L. Jr., Bueschen, A. J., Lloyd, K. L., Pretlow, T. P.: Enzyme activities in prostatic carcinoma related to Gleason Grades. Cancer Res., 45, 442 (1985).
2. Rackley, R. R., Lewis, T. J., Preston, E. M., Delmoro, C. M., Bradley, E, L. Jr., Resnick, M. I., Pretlow, T. P., Pretlow II, T. G.: 5-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia. Cancer Res., 49, 3702 (1989).
3. Rackley, R. R., Lewis, T. J., Bradley, E. L. Jr., Levin, H. S., Resnick, M. I., Pretlow, T. P., Pretlow II, T. G.: Enzymatic activities in extracts of small (20±5 mg) samples of prostatic carcinoma. Anal. Biochem., 184, 128 (1990).
4. Pretlow II, T. G., Nagabhushan, M., Sy, M., Guo, Y., Pretlow, T. P.: Putative preneoplastic foci in the human prostate. J. Cell Biochem. (Suppl.), 19, 224 (1994).
5. Chab, D. W., Sell, S.: Tietz Textbook of Clinical Chemistry. W. B. Saunders Co., Pennsylvania 1994.
6. Statland, B. E., Winkel, P.: Clinical Chemistry Theory, Analysis and Correlation. Mosby-Year Book Inc., Missouri 1996.
7. Mellerup, B.: Colorimetric method for rapid determination of serum arginase. Clin. Chem., 13, 900 (1967).
8. Yamanaka, H., Mayuzumi, T., Matsuoka, M., Shimazaki, J., Shida, K.: Arginase in human urogenital tumors. Gann., 63, 693 (1972).
9. Harris, B. E., Pretlow, T. P., Bradley, E. L. Jr., Whitehurst, G. B., Pretlow II, T. G.: Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. Cancer Res., 43, 3008 (1983).
10. Vafa, A. Z., Grover, P. K., Pretlow II, T. G., Resnick, M. I.: Study of activities of arginase, hexosaminidase and leucine aminopeptidase in prostate fluid. Urology, 42, 138 (1993).
11. Chinard, F. P.: Photometric estimation of proline and ornithine. J. Biol. Chem., 199, 91 (1952).
12. Gleason, D. F.: Classification of prostatic carcinomas. Cancer Chemother. Rep., 50, 125 (1966).
13. Gleason, D. F., Mellinger, G. T.: The Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., III, 58 (1974).
14. Gleason, D. F. and The Veterans Administration Cooperative Urologicai Research Group: Urologic Pathology: The Prostate. Lea & Febiger, Philadelphia 1977.
15. Williams-Ashman, H. G., Pegg, A. E., Lockwood, D. H.: Mechanisms and regulation of polyamine and putrescine biosynthesis in male genital glands and other tissues of mammals. Adv. Enzyme Regul., 7, 291 (1969).